Janus Living, Inc.
NYSEWhy this matters: Janus Living is flashing three distinct signals at once. Short positions have surged 52% in a month. The put/call ratio spiked to a 52-week high. Yet the borrow market remains wide open, and analysts keep lifting targets. The signals point in different directions — and that's the story. Seven firms have…
JAN short interest surges 24.6% in one week to 7.14M shares, though cost to borrow remains low at 0.43%.
Why this matters: Janus Living is flashing three distinct signals at once. Short positions have surged 52% in a month. The put/call ratio spiked to a 52-week high. Yet the borrow market remains wide open, and analysts…
Janus Living heads into September with a notable split: short sellers have stepped up their positioning sharply over the past month, even as analysts across the Street have been raising price targets in the wake of…
Snapshot as of 19 Sept 2026
JAN reports today after the close with analyst sentiment firmly constructive, a balance sheet reloaded with fresh capital, and short sellers showing no meaningful conviction against the stock. The bull case rests on an…
Janus Living enters the final stretch before its August 4 earnings with an unusual combination: bullish analyst momentum running in parallel with a sharp and sudden rebuild in short positioning. The most notable…
Janus Living heads into the back half of June with a notable shift: the aggressive short buildup that defined the past month is starting to reverse, just as analyst coverage reaches a new high-water mark. The freshest…
Janus Living enters mid-June with a striking divergence at its core: short sellers have nearly tripled their position over the past month while every analyst covering the stock has been raising targets. The short-side…
JAN enters the final days of May with a story that is squarely about analyst conviction meeting a stock that is finally responding. A cluster of target-price upgrades in the past three weeks has pushed JAN to $26.90 —…
Janus Living enters the market's spotlight this week with a rare alignment: heavy insider buying at IPO, a clean analyst sweep pointing to upside, and short interest rebuilding sharply — yet still too modest to…
Janus Living heads into its first earnings release as a public company with one of the more unusual setups in the REIT space: a near-unanimous analyst buy chorus, a stock that has already run well past most targets,…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JAN — free to start on ORTEX.
Sign up for free →Open JAN on ORTEX